close

Enter

Log in using OpenID

Unit Drug Dose Delivery System Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2019 to 2026

embed
Global Unit Drug Dose Delivery System Market is poised to register a CAGR of over 5% during the forecast period of 2019 to 2026.
Unit Drug Dose Delivery System Market Global Trends, Market Share, Industry Size,
Growth, Opportunities, and Market Forecast 2019 to 2026
Global Unit Drug Dose Delivery System Market is poised to register a CAGR of over
5% during the forecast period of 2019 to 2026.
Patients have to receive accurate dosing of drugs which will improve the recovery
rate of the patient hence unit drug delivery system is implemented by hospitals and
clinics. This system is also efficient in maintaining drug storage and its disposal. These
are some of the primary factors that drive the global unit drug delivery systems
market. Other than these factors, a rise in the demand for pre-filled syringes among
patients has also been the driving force for the growth of the market worldwide.
Additionally, healthcare and pharmaceutical industries are booming currently which
will certainly aid in drug delivery market growth during the forecast period. Key
market players are taking big strides in this market by expanding their production
capabilities along with a good geographical reach so that they can cement their
brand position.
Request a Sample Report @ https://www.futurewiseresearch.com/requestsample.aspx?id=223&page=requestsample
Insights on Global Unit Drug Delivery Systems market:
1. By Region
• North America
• Europe
• Asia Pacific
• Latin America
• Rest of the World
North America dominates the global market due to high drug awareness amongst
the general population resulting in deeper market penetration. Due to supportive
regulatory conditions for healthcare, Europe is the second most dominating region in
this market and this trend will continue throughout the entire forecast period. Asia
Pacific is a fast-growing region and is expected to witness a higher market growth
rate during the forecast period. One of the major reasons for this rise is due to a high
prevalence of chronic diseases and a large number of the patient population. Latin
America and Rest of the World account for a small global market share but are
expected to witness a rise in the growth rate during the forecast period due to rising
drug dosage awareness amongst general population leading to a rise in adoption of
newer and innovative techniques.
2.
•
o
•
By Material Type
Plastic
Polyethylene (PE)
High Density Polyethylene (HDPE)
• Low Density Polyethylene (LDPE)
o Poly Vinyl Chloride (PVC)
o Polystyrene
o Polycarbonate
o Polypropylene
o Polyethylene Terephthalate (PET)
• Glass
o Type 1
o Type 2
o Type 3
• Others
Plastic is poised to have a market share of around 60% by 2026 end which shows that
it is expected that plastic will dominate the global market during the forecast period.
Glass segment is also expected to see a steady rise during the forecast period.
3. By Product Type
• Solid
• Liquid
• Powder
The solid market segment accounted for a share of around 40% in 2017 and it is
expected to witness a consistent growth of the market during the forecast period.
Powder segment is also expected to experience a market growth during the forecast
period considering it had a market share of around 35% in 2017.
4. By End User
• Hospitals
• Clinics
• Outpatient Centres
Hospital segment dominates the global market due to the advanced facilities
provided by them and also the inception of multi-speciality hospitals has given them
more traction in the market and will continue to do so during the forecast period.
Clinics, on the other hand, are expected to maintain a significant market share during
the forecast period as average population from emerging economies prefer clinics
more than hospitals due to affordable costs.
Purchase a Copy of this Premium Research Report & Ask For Discount:
https://www.futurewiseresearch.com/requestsample.aspx?id=223&page=askfordiscount
Competitive Landscape:
• Amcor Ltd.
• Wipak Group
• R-Pharm
• Catalent Inc.
• Piramal Glass Ltd.
FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global unit drug dose delivery
system market by region, by material type, by product type, by end user
• To cater comprehensive information on factors impacting market growth (drivers,
restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)—North America,
Europe, Asia Pacific, Latin America, and Rest of the World
• To record evaluate and competitive landscape mapping- product launches,
technological advancements, mergers and expansions
• Profiling of companies to evaluate their market shares, strategies, financials and
core competencies
Table of Contents
1.1. Introduction
1.1.1.1. Scope and Objective
1.1.1.2. Assumptions and Acronyms
1.1.1.3. Forecast Factors
1.1.1.4. Research Methodology
1.2. Executive Summary
1.2.1.1. Industry Cluster Analysis
1.2.1.2. Competition Matrix
1.2.1.3. Strategies Recommendations
1.3. Market Definition
1.3.1.1. Report Scope (Inclusions & Exclusions)
1.3.1.2. Market Segmentation
1.4. Global Unit Drug Dose Delivery System Market Overview
1.4.1.1. Global Unit Drug Dose Delivery System Market Revenue (USD
Mn)
1.5. Key Inclusions
1.5.1.1. Porter’s Five Force analysis
1.5.1.2. Market Dynamics
1.5.1.3. Industry Trends
1.5.1.4. Regulatory Guidelines
1.5.1.5. Opportunities in Unit Drug Dose Delivery System
1.6. Competition Dynamics
1.6.1.1. Company Share Analysis (2018)
1.6.1.2. Top 10 Product Pricing by Region
1.7. Global Unit Drug Dose Delivery System Market Revenue (USD Mn), 20182026 by Product Type
1.7.1.1. Key Market Findings
1.7.1.2. Long Term ROI Segments
1.7.1.3. Revenue Opportunity Influencing Factors
1.7.1.4. Market Revenue (USD Mn) Assessment and Forecast by Product
Type, 2018-2026
1.7.1.4.1.1.
Blister Packaging
1.7.1.4.1.2.
Pre-filled Syringes
1.7.1.4.1.3.
Cartridges
1.7.1.4.1.4.
Vials
1.7.1.4.1.5.
Ampoules
1.8. Global Unit Drug Dose Delivery System Market Revenue (USD Mn), 20182026 by End User
1.8.1.1. Key Market Findings
1.8.1.2. Long Term ROI Segments
1.8.1.3. Revenue Opportunity Influencing Factors
1.8.1.4. Market Revenue (USD Mn) Assessment and Forecast by End
User, 2018-2026
1.8.1.4.1.1.
Hospitals
1.8.1.4.1.2.
Clinics
1.8.1.4.1.3.
Academics
1.8.1.4.1.4.
Outpatient Centres
1.9. Global Unit Drug Dose Delivery System Market Revenue (USD Mn), 20182026 by Region
1.9.1.1. Key Market Findings
1.9.1.2. Long Term ROI Segments
1.9.1.3. Revenue Opportunity Influencing Factors
1.9.1.4. Market Revenue (USD Mn) Assessment and Forecast by
Region,2026
1.9.1.4.1.1.
North America
1.9.1.4.1.2.
Latin America
1.9.1.4.1.3.
Europe
1.9.1.4.1.4.
Asia Pacific
1.9.1.4.1.5.
Rest of world
1.10.
North America Unit Drug Dose Delivery System Market Revenue (US$
Mn), 2018-2026
1.10.1.1. Key Market Findings
1.10.1.2. Long Term ROI Segments
1.10.1.3. Revenue Opportunity Influencing Factors
1.10.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
1.10.1.4.1.1.
US
1.10.1.4.1.2.
Canada
1.10.1.5. Market Revenue (USD Mn) Assessment and Forecast by Product
Type, 2018-2026
1.10.1.5.1.1.
Blister Packaging
1.10.1.5.1.2.
Pre-filled Syringes
1.10.1.5.1.3.
Cartridges
1.10.1.5.1.4.
Vials
1.10.1.5.1.5.
Ampoules
1.10.1.6. Market Revenue (USD Mn) Assessment and Forecast by End
User, 2018-2026
1.10.1.6.1.1.
Hospitals
1.10.1.6.1.2.
Clinics
1.10.1.6.1.3.
Academics
1.10.1.6.1.4.
Outpatient Centres
1.11.
Latin America Unit Drug Dose Delivery System Market Revenue (US$
Mn), 2018-2026
1.11.1.1. Key Market Findings
1.11.1.2. Long Term ROI Segments
1.11.1.3. Revenue Opportunity Influencing Factors
1.11.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
1.11.1.4.1.1.
Brazil
1.11.1.4.1.2.
Mexico
1.11.1.4.1.3.
Argentina
1.11.1.4.1.4.
Rest of Latin America
1.11.1.5. Market Revenue (USD Mn) Assessment and Forecast by Product
Type, 2018-2026
1.11.1.5.1.1.
Blister Packaging
1.11.1.5.1.2.
Pre-filled Syringes
1.11.1.5.1.3.
Cartridges
1.11.1.5.1.4.
Vials
1.11.1.5.1.5.
Ampoules
1.11.1.6. Market Revenue (USD Mn) Assessment and Forecast by End
User, 2018-2026
1.11.1.6.1.1.
Hospitals
1.11.1.6.1.2.
Clinics
1.11.1.6.1.3.
Academics
1.11.1.6.1.4.
Outpatient Centres
1.12.
Europe America Unit Drug Dose Delivery System Market Revenue
(US$ Mn), 2018-2026
1.12.1.1. Key Market Findings
1.12.1.2. Long Term ROI Segments
1.12.1.3. Revenue Opportunity Influencing Factors
1.12.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
1.12.1.4.1.1.
Germany
1.12.1.4.1.2.
France
1.12.1.4.1.3.
Spain
1.12.1.4.1.4.
UK
1.12.1.4.1.5.
Russia
1.12.1.4.1.6.
Poland
1.12.1.4.1.7.
Rest of Europe
1.12.1.5. Market Revenue (USD Mn) Assessment and Forecast by Product
Type, 2018-2026
1.12.1.5.1.1.
Blister Packaging
1.12.1.5.1.2.
Pre-filled Syringes
1.12.1.5.1.3.
Cartridges
1.12.1.5.1.4.
Vials
1.12.1.5.1.5.
Ampoules
1.12.1.6. Market Revenue (USD Mn) Assessment and Forecast by End
User, 2018-2026
1.12.1.6.1.1.
Hospitals
1.12.1.6.1.2.
Clinics
1.12.1.6.1.3.
Academics
1.12.1.6.1.4.
Outpatient Centres
1.13.
Asia Pacific America Unit Drug Dose Delivery System Market Revenue
(US$ Mn), 2018-2026
1.13.1.1. Key Market Findings
1.13.1.2. Long Term ROI Segments
1.13.1.3. Revenue Opportunity Influencing Factors
1.13.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
1.13.1.4.1.1.
Emerging Asia
1.13.1.4.1.1.1.1. China
1.13.1.4.1.1.1.2. India
1.13.1.4.1.1.1.3. ASEAN-5
1.13.1.4.1.1.1.4. Rest of Emerging Asia
1.13.1.4.1.2.
Japan
1.13.1.5. Market Revenue (USD Mn) Assessment and Forecast by Product
Type, 2018-2026
1.13.1.5.1.1.
Blister Packaging
1.13.1.5.1.2.
Pre-filled Syringes
1.13.1.5.1.3.
Cartridges
1.13.1.5.1.4.
Vials
1.13.1.5.1.5.
Ampoules
1.13.1.6. Market Revenue (USD Mn) Assessment and Forecast by End
User, 2018-2026
1.13.1.6.1.1.
Hospitals
1.13.1.6.1.2.
Clinics
1.13.1.6.1.3.
Academics
1.13.1.6.1.4.
Outpatient Centres
1.14.
Rest of World America Unit Drug Dose Delivery System Market
Revenue (US$ Mn), 2018-2026
1.14.1.1. Key Market Findings
1.14.1.2. Long Term ROI Segments
1.14.1.3. Revenue Opportunity Influencing Factors
1.14.1.4. Market Revenue (USD Mn) Assessment and Forecast by Country,
2018-2026
1.14.1.4.1.1.
Middle East
1.14.1.4.1.2.
South Africa
1.14.1.4.1.3.
North Africa
1.14.1.4.1.4.
Rest of World
1.14.1.5. Market Revenue (USD Mn) Assessment and Forecast by Product
Type, 2018-2026
1.14.1.5.1.1.
Blister Packaging
1.14.1.5.1.2.
Pre-filled Syringes
1.14.1.5.1.3.
Cartridges
1.14.1.5.1.4.
Vials
1.14.1.5.1.5.
Ampoules
1.14.1.6. Market Revenue (USD Mn) Assessment and Forecast by End
User, 2018-2026
1.14.1.6.1.1.
Hospitals
1.14.1.6.1.2.
Clinics
1.14.1.6.1.3.
Academics
1.14.1.6.1.4.
Outpatient Centres
1.15.
Company Profiles
1.15.1.1. Competition Landscape
1.15.1.2. Global Company Share (USD Mn) Overview, 2018
1.15.1.3. Company Profiles
1.15.1.3.1.1.
Mylan N.V
1.15.1.3.1.1.1.1. Corporate Overview
1.15.1.3.1.1.1.2. Financial Performance
1.15.1.3.1.1.1.3. Peer Comparison & 3C marketing equation
1.16.
1.15.1.3.1.1.1.4. Company Strategy & Channel Management
1.15.1.3.1.2.
Amedra Pharmaceuticals LLC
1.15.1.3.1.2.1.1. Corporate Overview
1.15.1.3.1.2.1.2. Financial Performance
1.15.1.3.1.2.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.2.1.4. Company Strategy & Channel Management
1.15.1.3.1.3.
Owen Mumford
1.15.1.3.1.3.1.1. Corporate Overview
1.15.1.3.1.3.1.2. Financial Performance
1.15.1.3.1.3.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.3.1.4. Company Strategy & Channel Management
1.15.1.3.1.4.
Ypsomed AG
1.15.1.3.1.4.1.1. Corporate Overview
1.15.1.3.1.4.1.2. Financial Performance
1.15.1.3.1.4.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.4.1.4. Company Strategy & Channel Management
1.15.1.3.1.5.
Antares Pharma
1.15.1.3.1.5.1.1. Corporate Overview
1.15.1.3.1.5.1.2. Financial Performance
1.15.1.3.1.5.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.5.1.4. Company Strategy & Channel Management
1.15.1.3.1.6.
SHL Group
1.15.1.3.1.6.1.1. Corporate Overview
1.15.1.3.1.6.1.2. Financial Performance
1.15.1.3.1.6.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.6.1.4. Company Strategy & Channel Management
1.15.1.3.1.7.
Johnson & Johnson
1.15.1.3.1.7.1.1. Corporate Overview
1.15.1.3.1.7.1.2. Financial Performance
1.15.1.3.1.7.1.3. Peer Comparison & 3C marketing equation
1.15.1.3.1.7.1.4. Company Strategy & Channel Management
Research Sources & Primary Verbatim
Inquire further details about this report at: [email protected]
About FutureWise Research:
We specialise in high-growth niche markets, assuring flexibility, agility and
customised solutions for our clients. Through in-depth market insights and
consultancy, we present our clients with the tools they need to be at the forefront of
their industry – a position secured for far more than the near future.
Contact Us:
Company Name: FutureWise Research
Contact Person: Vinay Thaploo
Email: [email protected]
Phone: +44 141 628 9353 / +1 970 279 4295
City: Leeds
Country: United Kingdom
Website: www.futurewiseresearch.com
1/--pages
Report inappropriate content